Portfolio company
DaltonTx
United Kingdom · £4.0m raised
Raised
£4.0m
Latest stage
Seed
Rounds recorded
1
Backed by
2 investors
Sectors
About
This company provides an adaptive artificial intelligence platform for drug discovery to pharmaceutical, biotechnology and contract research organisations.
SourceFunding history · 1
Similar companies
DeepMirror
This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.
Axiom Therapeutics
This deep-tech company develops covalent medicines for pharmaceutical organisations using an artificial intelligence drug discovery platform.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
AI-DRIVEN CHEMISTRY
This company provides a machine learning platform to help pharmaceutical and chemical organisations accelerate research and development by optimizing experiments using small datasets.
Aqemia
This company develops a drug discovery platform using physics-based algorithms and artificial intelligence for pharmaceutical and biotechnology organisations.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Inductive Bio
This company provides a machine learning platform for compound optimization and ADMET prediction to biopharma and drug discovery organisations.
Avicenna Biosciences
The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.
